Evidence map›Paper›PMID 36204522›Full record

ArticleThe journal of medicine access

Telemedicine in a primary care clinic in Fairbanks, Alaska: Not a magic bullet for providing treatment during COVID-19.

Sarah Yt Hartzell

Abstract readEditorial
In one paragraph

Article in The journal of medicine access. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Sarah Yt HartzellSchool of Public Health, University of Nevada, Reno, Reno, NV, USA.ORCID https://orcid.org/0000-0002-7041-6891

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stay-at-home orders due to the COVID-19 pandemic have increased patients' reliance on virtual physician visits, via telemedicine. Telemedicine has benefits of use during the pandemic and has benefits outside of the pandemic. It is underutilized in certain types of medical organizations, providers, and among specific populations in the United States. It is important to understand the barriers to incorporating telemedicine effectively in the areas that it is underutilized, especially in rural locations. The researcher discussed the telemedicine expansion for two family practice doctors in Fairbanks, Alaska (AK). The family practice doctors experienced barriers that partially echo what has been stated in research. Research suggests that changes to Medicare and Medicaid telemedicine policies may not be enough to address these barriers. Other supports to expand telemedicine where it is needed includes providing more incentives to providers, waivers from insurance companies for patients to purchase equipment, and more education to patients about when, how, and where to receive telemedicine. More supports need to be provided to those underserved by telemedicine, especially for clients who are on Medicaid, living in low-income areas, and/or living in rural locations.

Indexed as

barriersCOVID-19ruraltechnologytelemedicine

Identifiers

PMID36204522
PMCPMC9413496

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.